Clinical data Trade names
Parabolan, Hexabolan Synonyms
Trenbolone cyclohexylmethylcarbonate; Estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate Routes of administration
Intramuscular injection Drug class
Androgen; Anabolic steroid; Androgen ester; Progestogen Identifiers
Cyclohexylmethyl [(8 S,13 S,14 S,17 S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1 H-cyclopenta[ a]phenanthren-17-yl] carbonate CAS Number
Chemical and physical data Formula
C 26 H 34 O 4 Molar mass
410.554 g/mol 3D model ( JSmol)
Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.
It was introduced in France in 1980 and was voluntarily discontinued by its manufacturer in 1997.
 Trenbolone hexahydrobenzylcarbonate half-life is approximately 14 days  . The drug acts as a long-lacting  prodrug of trenbolone when administered via intramuscular injection.
See also [ edit ]
References [ edit ]
Further reading [ edit ]
Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi: 10.1016/j.steroids.2010.01.019. PMID 20138077.
External links [ edit ]